BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18661512)

  • 1. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
    Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
    Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; McMillan A
    Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.
    Weber F; Shen L; Aldred MA; Morrison CD; Frilling A; Saji M; Schuppert F; Broelsch CE; Ringel MD; Eng C
    J Clin Endocrinol Metab; 2005 May; 90(5):2512-21. PubMed ID: 15713710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECM1 expression in thyroid tumors--a comparison of real-time RT-PCR and IHC.
    Lal G; Padmanabha L; Nicholson R; Smith BJ; Zhang L; Howe JR; Robinson RA; O'Dorisio MS
    J Surg Res; 2008 Sep; 149(1):62-8. PubMed ID: 18374945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UbcH10 expression on thyroid fine-needle aspirates.
    Guerriero E; Ferraro A; Desiderio D; Pallante P; Berlingieri MT; Iaccarino A; Palmieri E; Palombini L; Fusco A; Troncone G
    Cancer Cytopathol; 2010 Jun; 118(3):157-65. PubMed ID: 20544706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
    Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
    Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
    Jeronimo C; Monteiro P; Henrique R; Dinis-Ribeiro M; Costa I; Costa VL; Filipe L; Carvalho AL; Hoque MO; Pais I; Leal C; Teixeira MR; Sidransky D
    Breast Cancer Res Treat; 2008 May; 109(1):27-34. PubMed ID: 17549626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
    Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Ann Surg; 2005 Sep; 242(3):353-61; discussion 361-3. PubMed ID: 16135921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
    Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
    Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
    Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
    Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
    Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry.
    Feilchenfeldt J; Tötsch M; Sheu SY; Robert J; Spiliopoulos A; Frilling A; Schmid KW; Meier CA
    Mod Pathol; 2003 Nov; 16(11):1117-23. PubMed ID: 14614051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency.
    Krause K; Eszlinger M; Gimm O; Karger S; Engelhardt C; Dralle H; Fuhrer D
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1390-3. PubMed ID: 18198227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic markers to discriminate benign and malignant thyroid nodules with undetermined cytology in an area of borderline iodine deficiency.
    Tonacchera M; Agretti P; Rago T; De Marco G; Niccolai F; Molinaro A; Scutari M; Candelieri A; Conforti D; Musmanno R; Di Coscio G; Basolo F; Iacconi P; Miccoli P; Pinchera A; Vitti P
    J Endocrinol Invest; 2012 Sep; 35(8):754-9. PubMed ID: 21979329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling.
    Suh I; Shibru D; Eisenhofer G; Pacak K; Duh QY; Clark OH; Kebebew E
    Ann Surg; 2009 Dec; 250(6):983-90. PubMed ID: 19661783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
    Vriens MR; Weng J; Suh I; Huynh N; Guerrero MA; Shen WT; Duh QY; Clark OH; Kebebew E
    Cancer; 2012 Jul; 118(13):3426-32. PubMed ID: 22006248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of genetic biomarkers for distinguishing benign from malignant thyroid neoplasms.
    Nagar S; Ahmed S; Peeples C; Urban N; Boura J; Thibodeau B; Akervall J; Wilson G; Long G; Czako P
    Am J Surg; 2014 Apr; 207(4):596-601. PubMed ID: 24713092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.